CTKB — Cytek Biosciences, Inc. | XLV Holdings | StockAdder

(CTKB)

Cytek Biosciences, Inc.

Live chart and latest CTKB stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

CTKB News

Cytek Biosciences (CTKB) Inspiring Confidence With Aurora CS System Updates

Apr 14, 2026 Stock Titan

Millennium Group reports 6.64M shares in Cytek Biosciences (CTKB)

Apr 9, 2026 Gotrade

Cytek Biosciences, Inc. Common Stock (CTKB) Stock Price Today & Analysis

Jan 13, 2026 simplywall.st

Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Share Price Is Still Matching Investor Opinion Despite 27% Slump

Feb 13, 2026 Quiver Quantitative

Cytek Biosciences Reports Preliminary Revenue of Approximately $201 Million for Full Year 2025

Jan 12, 2026 Seeking Alpha

Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth (CTKB)

Nov 20, 2025 Yahoo Finance

Cytek Biosciences (CTKB): Evaluating Valuation After TIME’s 2026 Growth Leaders Recognition and Recurring Revenue Momentum

Nov 17, 2025 Stock Titan

Cell analysis firm Cytek shows faster Q4 sales growth in 2025

Jan 12, 2026 simplywall.st

Can Cytek Biosciences' (CTKB) Steady Outlook Offset Its Shift to Losses?

Nov 15, 2025 Seeking Alpha

Cytek Biosciences: Growth Over Profit Will Pay Off In The Long Term (NASDAQ:CTKB)

Sep 9, 2025 Stock Titan

Vanguard realignment leaves Cytek (NASDAQ: CTKB) ownership at 0 after amendment

Mar 26, 2026 Yahoo Finance

How The Cytek Biosciences (CTKB) Story Is Shifting With New Targets And 2026 Guidance

Mar 8, 2026 simplywall.st

Cytek Biosciences Insiders May Regret Not Buying More, Market Cap Hits US$510m

Nov 7, 2025 Stock Titan

Cytek Biosciences (Nasdaq: CTKB) in TIME–Statista 2026 Growth Leaders inaugural ranking

Nov 12, 2025 simplywall.st

Cytek Biosciences (CTKB): Evaluating Valuation After TIME's Growth Leaders 2026 Recognition